Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ansorge

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
Cell Reports|December 15, 2015
Activity of Raphé Serotonergic Neurons Controls Emotional BehaviorsAnne Teissier, Alexei Chemiakine, Benjamin Inbar, et al.
Circulation|June 14, 2000
Regulation of angiotensin II receptor subtypes during atrial fibrillation in humansA Goette, M Arndt, C Röcken, et al.
The Journal of Biological Chemistry|December 31, 1997
The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growthS Wrenger, T Hoffmann, J Faust, et al.
The Journal of Biological Chemistry|July 18, 2000
Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptorS Wrenger, J Faust, C Mrestani-Klaus, et al.
Advances in Experimental Medicine and Biology|June 13, 2000
Dipeptidyl peptidase IV in inflammatory CNS diseaseA Steinbrecher, D Reinhold, L Quigley, et al.
Advances in Experimental Medicine and Biology|June 13, 2000
Dipeptidyl peptidase IV (CD26): role in T cell activation and autoimmune diseaseD Reinhold, B Hemmer, B Gran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivoA Steinbrecher, D Reinhold, L Quigley, et al.
ACS Chemical Neuroscience|December 28, 2017
Toward Serotonin Fluorescent False Neurotransmitters: Development of Fluorescent Dual Serotonin and Vesicular Monoamine Transporter Substrates for Visualizing Serotonin NeuronsAdam Henke, Yekaterina Kovalyova, Matthew Dunn, et al.
Birth Defects Research|July 18, 2017
New Insights into How Serotonin Selective Reuptake Inhibitors Shape the Developing BrainJay A Gingrich, Heli Malm, Mark S Ansorge, et al.
The Journal of Clinical Investigation|November 19, 2019
Chemogenetic activation of adrenocortical Gq signaling causes hyperaldosteronism and disrupts functional zonationMatthew J Taylor, Matthew R Ullenbruch, Emily C Frucci, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Cell Reports|December 15, 2015
Activity of Raphé Serotonergic Neurons Controls Emotional BehaviorsAnne Teissier, Alexei Chemiakine, Benjamin Inbar, et al.
Circulation|June 14, 2000
Regulation of angiotensin II receptor subtypes during atrial fibrillation in humansA Goette, M Arndt, C Röcken, et al.
The Journal of Biological Chemistry|December 31, 1997
The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growthS Wrenger, T Hoffmann, J Faust, et al.
The Journal of Biological Chemistry|July 18, 2000
Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptorS Wrenger, J Faust, C Mrestani-Klaus, et al.
Advances in Experimental Medicine and Biology|June 13, 2000
Dipeptidyl peptidase IV in inflammatory CNS diseaseA Steinbrecher, D Reinhold, L Quigley, et al.
Advances in Experimental Medicine and Biology|June 13, 2000
Dipeptidyl peptidase IV (CD26): role in T cell activation and autoimmune diseaseD Reinhold, B Hemmer, B Gran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivoA Steinbrecher, D Reinhold, L Quigley, et al.
ACS Chemical Neuroscience|December 28, 2017
Toward Serotonin Fluorescent False Neurotransmitters: Development of Fluorescent Dual Serotonin and Vesicular Monoamine Transporter Substrates for Visualizing Serotonin NeuronsAdam Henke, Yekaterina Kovalyova, Matthew Dunn, et al.
Birth Defects Research|July 18, 2017
New Insights into How Serotonin Selective Reuptake Inhibitors Shape the Developing BrainJay A Gingrich, Heli Malm, Mark S Ansorge, et al.
The Journal of Clinical Investigation|November 19, 2019
Chemogenetic activation of adrenocortical Gq signaling causes hyperaldosteronism and disrupts functional zonationMatthew J Taylor, Matthew R Ullenbruch, Emily C Frucci, et al.
Pageof 22